Herceptin

In the US, Herceptin (trastuzumab systemic) is a member of the drug class HER2 inhibitors and is used to treat Breast Cancer, Breast Cancer - Adjuvant, Breast Cancer - Metastatic, Esophageal Carcinoma, Gastric Cancer and Salivary Gland Cancer.

US matches:

• Herceptin

UK matches:

• Herceptin 150mg Powder for concentrate for solution for infusion (SPC)

Ingredient matches for Herceptin

Trastuzumab

Trastuzumab is reported as an ingredient of Herceptin in the following countries:

• Algeria


• Argentina


• Australia


• Austria


• Bahrain


• Bangladesh


• Belgium


• Benin


• Bolivia


• Bosnia & Herzegowina


• Brazil


• Canada


• Chile


• China


• Colombia


• Costa Rica


• Croatia (Hrvatska)


• Cuba


• Cyprus


• Czech Republic


• Denmark


• Ecuador


• Egypt


• Estonia


• Finland


• France


• Georgia


• Germany


• Greece


• Hong Kong


• Hungary


• Iceland


• India


• Indonesia


• Iran


• Iraq


• Ireland


• Israel


• Italy


• Jamaica


• Japan


• Jordan


• Kazakhstan


• Kuwait


• Lebanon


• Lithuania


• Luxembourg


• Malaysia


• Mexico


• Moldova


• Morocco


• Netherlands


• New Zealand


• Norway


• Oman


• Pakistan


• Paraguay


• Philippines


• Poland


• Portugal


• Qatar


• Romania


• Russian Federation


• Saudi Arabia


• Serbia


• Singapore


• Slovakia


• Slovenia


• South Africa


• Sri Lanka


• Sweden


• Switzerland


• Syria


• Taiwan


• Thailand


• Trinidad & Tobago


• Tunisia


• Turkey


• United Arab Emirates


• United Kingdom


• United States


• Uruguay


• Uzbekistan


• Venezuela


• Yemen

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.